9,893
Total Claims
$731K
Drug Cost
757
Beneficiaries
$966
Cost/Patient
Peer Comparison vs. 16,767 Hospitalist providers
-84%
Opioid rate vs peers
0.5% vs 3.0% avg
+126%
Cost per patient vs peers
$966 vs $427 avg
+101%
Brand preference vs peers
10.5% vs 5.2% avg
Opioid Prescribing
0.5%
Opioid Rate
48
Opioid Claims
$122
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
90% generic
Brand: 1,031 claims · $587K
Generic: 8,779 claims · $140K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 138 | $115K |
| Apixaban | 96 | $92K |
| Rivaroxaban | 57 | $66K |
| Dapagliflozin Propanediol | 29 | $31K |
| Empagliflozin | 30 | $27K |
| Liraglutide | 14 | $24K |
| Semaglutide | 21 | $23K |
| Insulin Glargine,hum.Rec.Anlog | 44 | $20K |
| Mirabegron | 28 | $15K |
| Insulin Degludec | 26 | $14K |
| Budesonide/Formoterol Fumarate | 29 | $12K |
| Sacubitril/Valsartan | 16 | $11K |
| Ipratropium/Albuterol Sulfate | 14 | $7,174 |
| Atorvastatin Calcium | 557 | $6,913 |
| Amlodipine Besylate | 912 | $6,668 |
Prescribing Profile
Patient Profile
78
Avg Age
56%
Female
1.41
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About